Cgi Pharmaceuticals, Inc.
Records under this name other than patents Cgi Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cgi Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,625,931 | Certain substituted diphenyl ureas, as modulators of kinase activity Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,838,523 | Certain substituted amides, method of making, and method of use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,884,108 | Certain substituted pyrazinones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,247,550 | Certain substituted amides, method of making, and method of use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,947,835 | Certain substituted amides, method of making, and method of use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,426,424 | Certain Substituted Amides, Method of Making, and Method of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 7,777,040 | Certain substituted ureas, as modulators of kinase activity Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,450,321 | 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,455,493 | Imidazopyrazine Syk Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,962,835 | Imidazopyrazine Syk Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence |